Creatinine Clearance Is Associated with Toxicity from Molecularly Targeted Agents in Phase I Trials

Por Basu, B., Vitfell-Pedersen, J., Moreno Garcia, V., Puglisi, M., Tjokrowidjaja, A., Shah, K., Malvankar, S., Anghan, B., de Bono, J.S., Kaye, S.B., Molife, L.R., Banerji, U.
Publicado no Oncology (2012)